LivaNova (LIVN)
NASDAQ: LIVN
· Real-Time Price · USD
53.86
-0.27 (-0.50%)
At close: Aug 15, 2025, 10:18 AM
-0.50% (1D)
| Bid | 53.81 |
| Market Cap | 2.94B |
| Revenue (ttm) | 1.31B |
| Net Income (ttm) | -211.32M |
| EPS (ttm) | -3.88 |
| PE Ratio (ttm) | -13.88 |
| Forward PE | 12.26 |
| Analyst | Buy |
| Ask | 53.94 |
| Volume | 60,080 |
| Avg. Volume (20D) | 662,891 |
| Open | 54.40 |
| Previous Close | 54.13 |
| Day's Range | 53.86 - 54.72 |
| 52-Week Range | 32.48 - 57.35 |
| Beta | 0.93 |
About LIVN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LIVN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for LIVN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
LivaNova has released their quartely earnings
on Aug 6, 2025:
Next Earnings Release
LivaNova is scheduled to release its earnings on
Oct 29, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
+11.15%
LivaNova shares are trading higher after the compa...
Unlock content with
Pro Subscription
3 months ago
+23.72%
LivaNova shares are trading higher after the company reported better-than-expected Q1 financial results and issued FY25 guidance above estimates.
3 months ago · businesswire.com
LivaNova to Present at the Jefferies Global Healthcare ConferenceLONDON--(BUSINESS WIRE)-- #OSA--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced Vladimir Makatsaria, Chief Executive Officer, will participate in a fireside c...